Clinical Trial Update: Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients [Phase 1]

View source ↗

Summary

Phase 1 study of ARO-ANG3 in healthy volunteers and dyslipidemic patients has completed; the update provides status of the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias
• Familial Hypercholesterolemia
• Hypertriglyceridemia

Drugs mentioned

• ARO-ANG3

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Dyslipidemias, Familial Hypercholesterolemia | Phase 1 | Status: COMPLETED